Maarten has previous experience in Health Technology Assessment as a committee member of MSAC and PBAC (2019-2022) in Australia and as a Chair of the Pharmacoeconomic Guidelines committee (2015-2016) in the Netherlands. He was involved in intertnational taskforces developing methodological guidance for the use of Dynamic Simulation Modelling, Multi-Criteria Decision Making, Constrained Optimisation and Structured Expert Elicitation. Following his PhD in biomedical engineering, he developed an interest in early HTA, a collection of methods and approaches to inform medical product development. His current research is focussed on the health economics and health services implications of personalised oncology, including research on the real-world evidence of drug treatment sequencing, implementation of complex genomic sequencing and health systems modelling of (equitable) access to cancer care. He is an investigator on several programs, including the Victorian Comprehensive Cancer Centre (VCCC) and The Advanced Genomics Collaboration (Illumina and University of Melbourne). He is a chief investigator on the MRFF funded “PRedicting health economic IMpact of new CAncer Treatments” (PRIMCAT) project.
Since 2022, he is the chair of the Rotterdam Global Health Initiative (RGHI), the chair of ISPOR’s Health Sciences Policy Council and a non-executive board member in different organisations in the private and non-private sector.